Your session is about to expire
← Back to Search
CARE Program + Valera App Interventions for Parenting Challenges During Coronavirus (CARE Trial)
N/A
Recruiting
Led By Vilma Gabbay, MD
Research Sponsored by Albert Einstein College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Primary language other than Spanish or English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 24
Awards & highlights
No Placebo-Only Group
Summary
This trial tests the CARE program and Valera Health app to help stressed caregivers in the Bronx. The CARE program offers group sessions for emotional support, while the Valera Health app provides digital mental health resources. These interventions aim to reduce stress and improve mental health among caregivers.
Who is the study for?
This trial is for primary caregivers in the Bronx experiencing high stress, especially those working on-site at Montefiore Medical Center or patients in psychiatric and rheumatology clinics there. It includes grandmothers and aunts but excludes those with neurocognitive issues, serious psychiatric/substance use problems, active child abuse cases, non-Spanish/English speakers, or prior similar app users.
What is being tested?
The study tests various combinations of the CARE Program and Valera Application to alleviate parental stress due to COVID-19. Some will use both tools with added care manager support; others will try each tool separately or combined without extra support.
What are the potential side effects?
Since this trial involves psychological interventions rather than medications, traditional side effects are not expected. However, participants may experience emotional discomfort when discussing personal challenges related to parenting during the pandemic.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My primary language is not English or Spanish.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 24
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 24
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Perceived Stress
Secondary study objectives
Beck Anxiety Index
Beck Depression Index
Beck Suicide Scale Inventory
+5 moreOther study objectives
Alcohol Use Disorders Identification Test (Audit C)
COVID Impact Scale
Drug Abuse Screening Test
+15 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Parents of children receiving mental health treatment at MontefioreExperimental Treatment3 Interventions
Participants will either CARE program alone; b) Valera Health app; c) CARE program and Valera Health app .
Group II: Parents of children being treated for autoimmune disorders at MontefioreExperimental Treatment3 Interventions
Participants will either CARE program alone; b) Valera Health app; c) CARE program and Valera Health app.
Group III: Healthcare workers at MontefioreExperimental Treatment3 Interventions
Participants will either CARE program alone; b) Valera Health app; c) CARE program and Valera Health app.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The multimodal parent-focused intervention includes strategies such as psychological support, financial assistance, and telehealth services. Psychological support mechanisms often involve cognitive-behavioral therapy (CBT) to help parents manage stress, anxiety, and depression by changing negative thought patterns and behaviors.
Financial assistance aims to alleviate economic stressors that can exacerbate mental health issues. Telehealth services provide accessible healthcare options, reducing barriers to receiving timely support.
These mechanisms are crucial for parenting patients as they help mitigate the psychological and health impacts of the pandemic, enabling parents to provide better care and support for their children, thereby breaking potential cycles of stress and trauma.
Diagnosis and management of trichotillomania in children and adolescents.
Diagnosis and management of trichotillomania in children and adolescents.
Find a Location
Who is running the clinical trial?
Albert Einstein College of MedicineLead Sponsor
296 Previous Clinical Trials
11,688,593 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,933 Previous Clinical Trials
2,745,678 Total Patients Enrolled
7 Trials studying Parenting
760 Patients Enrolled for Parenting
Vilma Gabbay, MDPrincipal InvestigatorAlbert Einstein College of Medicine
2 Previous Clinical Trials
440 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My primary language is not English or Spanish.You have a serious mental health or substance use problem that would make it difficult for you to fully take part in the study.I do not have any mental conditions that would stop me from using online health services.Used a health app like the Valera app on a smartphone.You are the main caregiver and have a high perceived stress score on the Perceived Stress Scale.You must be currently receiving care at the psychiatric and rheumatology clinics in Montefiore Medical Center (MMC).You are currently involved in a case of child abuse or maltreatment.
Research Study Groups:
This trial has the following groups:- Group 1: Parents of children receiving mental health treatment at Montefiore
- Group 2: Parents of children being treated for autoimmune disorders at Montefiore
- Group 3: Healthcare workers at Montefiore
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.